Integrating artificial intelligence across the cancer drug discovery pipeline using a design-test-refine workflow
Artificial intelligence-driven drug design (AIDD) is increasingly transforming cancer drug discovery, but its applications are often considered as individual computational tasks rather than interconnected stages of the drug discovery pipeline. This mini-review addresses this gap by firstly identifying the following fou...